Journal article icon

Journal article

The treatment of severe malaria.

Abstract:

In the SEAQUAMAT trial, parenteral artesunate was shown to be associated with a considerably lower mortality than quinine, and is now the recommended treatment for severe malaria in low-transmission areas and in the second and third trimesters of pregnancy. A trial is underway to establish its role in African children. The development of artesunate suppositories may provide the means to treat patients with severe disease in remote rural settings, potentially buying the time needed to reach a ...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Thailand/Laos MOP
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Thailand/Laos MOP
Journal:
Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume:
101
Issue:
7
Pages:
633-634
Publication date:
2007-07-05
DOI:
EISSN:
1878-3503
ISSN:
0035-9203
URN:
uuid:f7233012-13eb-4b7c-b32e-a8872b6c0f51
Source identifiers:
33820
Local pid:
pubs:33820

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP